Obesity, type 2 diabetes mellitus (T2DM) and aging are associated with pancreatic cancer risk, but the mechanisms of pancreatic cancer development caused by these factors are not clearly understood. Syrian golden hamsters are susceptible to Nnitrosobis(2-oxopropyl)amine (BOP)-induced pancreatic carcinogenesis. Aging, BOP treatment and/or a high-fat diet cause severe and scattered fatty infiltration (FI) of the pancreas with abnormal adipokine production and promote pancreatic ductal adenocarcinoma (PDAC) development. The KK-A y mouse, a T2DM model, also develops severe and scattered FI of the pancreas. Treatment with BOP induced significantly higher cell proliferation in the pancreatic ducts of KK-A y mice, but not in those of ICR and C57BL/6J mice, both of which are characterized by an absence of scattered FI. Thus, we hypothesized that severely scattered FI may be involved in the susceptibility to PDAC development. Indeed, severe pancreatic FI, or fatty pancreas, is observed in humans and is associated with age, body mass index (BMI) and DM, which are risk factors for pancreatic cancer. We analyzed the degree of FI in the non-cancerous parts of PDAC and non-PDAC patients who had undergone pancreatoduodenectomy by histopathology and demonstrated that the degree of pancreatic FI in PDAC cases is significantly higher than that in non-PDAC controls.
and etiology and to develop prevention methods against it. We have studied the risk and preventive factors for pancreatic cancer using animal models. [2] [3] [4] Syrian golden hamsters are susceptible to chemically induced pancreatic carcinogenesis. 5 Screening of preventive agents for pancreatic cancer has been carried out using this animal model because mice and rats are not usually susceptible to chemically induced pancreatic carcinogenesis. 6 Recently, mouse models of pancreatic cancer, such as genetically engineered mouse models and patient-derived xenograft models, have been developed and used in preclinical studies for cancer therapy, 7 but these models may not be suitable for studying carcinogenic/anti-carcinogenic factors. There are species differences in pancreatic cancer susceptibility. If we can clarify the reason why Syrian golden hamsters are susceptible to pancreatic carcinogenesis, it may be helpful to understand the factors that are related to pancreatic cancer susceptibility and to develop preventive methods against them. Syrian golden hamsters develop hypertriglyceridemia and fatty infiltration (FI) of the pancreas, and the severity of FI increases along with the progression of carcinogenesis. 2 However, the association of FI with pancreatic cancer in other animals has not yet been clarified. We then investigated whether FI of the pancreas, or a pancreas with FI per se, was an essential modification factor for pancreatic carcinogenesis in both experimental animals and humans.
Epidemiological studies have shown that obesity and type 2 diabetes mellitus (T2DM) are risk factors for pancreatic cancer. 8 Obesity and T2DM accompany dyslipidemia and visceral fat accumulation, 9 and ectopic fats are observed in the liver, heart, muscle, and pancreas [10] [11] [12] and cause lipotoxicity in these organs. 13 In particular, hepatic steatosis, also known as non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH), promotes hepatocellular carcinoma and cholangiocarcinoma development. 14, 15 Recently, lipid deposition in the pancreas (fatty pancreas) has been studied in relationship to non-alcoholic fatty pancreatic diseases (NAFPD), 10 and the involvement of fatty pancreas in pancreatic carcinogenesis has been suggested. 16, 17 In this review, we focus on the contribution of pancreatic FI to pancreatic carcinogenesis in humans and animal models and discuss the putative mechanisms. There are multiple risk factors for fatty pancreas. 21 The degree of pancreatic fat is positively associated with age and body mass index (BMI). 22 It has been reported that pancreatic fat increases with age until~60 years and then reaches a plateau, while the parenchymal pancreas volume increases with age until~30 years and then gradually decreases; these factors increase the fat/parenchymal ratio in middle-aged and elderly people. 23 In the case of obesity, the parenchymal pancreas volume increases by approximately 10%-15%, whereas pancreatic fat mass increases by~70% compared to that of lean subjects, resulting in an increase in the fat/parenchymal ratio. 23 Analysis of 685 subjects in a general population cohort study of adult Hong Kong Chinese volunteers revealed that the prevalence of fatty pancreas increased with age, in general, but there were also sex differences. The prevalence of fatty pancreas in men peaked from 40 to 49 years. On the other hand, the prevalence of fatty pancreas was very low in women <50 years old, but increased progressively to age 60. 24 These results suggest that the overweight/ obesity in middle-aged men and the hypercholesterolemia in postmenopausal women may be involved in the development of fatty pancreas. Compared to adults, pancreatic fat levels were low in children, but the pancreatic fat ratio in overweight/obese children with fatty liver was higher than that in overweight/obese children without fatty liver (2.28% vs 1.77%). 
| WH AT IS

| Fatty pancreas-associated disease
Fatty pancreas is associated with abdominal obesity, insulin resistance, T2DM, dyslipidemia, arterial hypertension and metabolic syndrome. 26, 27 In non-obese T2DM patients, a significant association between pancreatic steatosis and atherosclerosis has been reported. 28 In addition, fatty liver is one of the risk factors for fatty pancreas. 29 Infection and autoimmune diseases are also involved in the development of fatty pancreas. 22 
| Fatty pancreas in experimental animals
In experimental animals, there are species-and strain-specific differences in the pancreatic FI patterns.
| Syrian golden hamsters
The Syrian golden hamster is a unique animal model that develops pancreatic ductal adenocarcinoma (PDAC) when given subcutaneous injections of N-nitrosobis(2-oxopropyl)amine (BOP). 35 Syrian golden hamsters have both severely scattered intralobular fat and accumulation of interlobular fat that is mainly observed around large vessels ( Figure 1E ), 2 similar to that seen in humans with severe pancreatic FI. Figure 1K ,L). 39 Matsuda et al. 40 reported that intralobular fat increased with age and with a high-fat diet in Zucker diabetic fatty rats, although pancreatic FI in these rats was moderate compared to that observed in Syrian golden hamsters.
| Possible etiology and genetic predisposition 2.4.1 | Possible etiology
The species-and strain-specific differences in the FI patterns described above suggest that the etiology of scattered intralobular FI is different from that of the interlobular fat accumulation that is mainly observed around large vessels in the pancreas. In the case of scattered intralobular fat, adipocytes appear independent from the vessels and are assumed to be produced by the transformation of fibroblasts or acinar cells to occupy the space created by the loss of damaged acinar cells. High levels of triglycerides and glucose, or ischemia induced by atherosclerosis, are considered to be cytotoxic effects. Scattered FI is only observed in a limited number of species or strains, and severe fatty pancreas often accompanies this scattered FI, so there may be genetic backgrounds related to the susceptibility to acinar cell damage. Of note, these speculations need to be proven by further experiments. On the other hand, interlobular fat accumulation, mainly observed around large vessels in the pancreas, is widely observed in most species and seems to be associated with obesity/T2DM. Similarly, perivascular fat of the liver has been observed in fatty liver subjects. 41 Perivascular fat is an ectopic fat and affects atherosclerosis. 42 Perivascular mesenchymal stem cells were shown to differentiate into adipocytes in an adipogenic differentiation medium containing dexamethasone, 3-isobutyl-1-methylxanthine, insulin and indomethacin. 43 Hyperinsulinemia in obesity/ T2DM and stress-induced glucocorticoid production may prompt the differentiation of perivascular mesenchymal stem cells to adipocytes.
| Possible genetic predisposition for fatty pancreas
Genetic predisposition for fatty pancreas has not yet been clarified.
Thus, we propose several speculations that are based on other diseases, such as NAFLD and DM, or derived from animal experiments.
Several causative genes of NAFLD have been proposed by casecontrol studies, 44 and there is a strong association of the Patatin-like phospholipase domain-containing 3 gene variant rs738409(C > G) (I148M) with the development and progression of NASH-and NAFLD-related hepatocellular carcinoma. 45 Fatty liver is one of the risk factors for fatty pancreas, 29 so causative genes for NAFLD may be involved in the development of fatty pancreas.
As a functional candidate gene for T2DM, CD44 has been identified by an expression-based genome-wide association study. 46 CD44
variant expression is known to be associated with poor prognosis in pancreatic cancer. 47 In addition, CD44 expression is increased in inflammatory cells in obese adipose tissue, and anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice. 48 In hypoxia, CD44 is co-expressed with Sca-1 in adipose tissue-derived mesenchymal stem cells and enhances adipogenic differentiation. 49 In addition, a diabetes-related gene variant, rs1501299(A > C) in the ADPIOQ gene, has been shown to be positively associated with pancreatic cancer in Japanese patients. 50 This variant is correlated with adiponectin levels, and low adiponectin levels contribute to insulin resistance. (Table 1) . 2 Syrian golden hamsters have hyperlipidemia, and the hepatic lipoprotein lipase activity in Syrian golden hamsters is lower compared with that of C57BL/6J mice and F344/ Wistar rats. 4 A high-fat diet elevates serum lipid levels and exacerbates pancreatic FI in Syrian golden hamsters. 2 The developmental period of BOP-induced PDAC was shortened, and the numbers of PDAC at 25 weeks of age were increased 2-fold by the consumption of a high-fat diet (Table 1) . 2 BOP induces a K-ras gene mutation, which plays an essential role in pancreatic carcinogenesis. 57 Fatty pancreas itself cannot induce PDAC development (Table 1) , but reactivity to BOP may be associated with a pancreas that is susceptible to damage and easily infiltrated by adipocytes. Indeed, a single high dose of BOP activated pancreatic ductal cell proliferation. 58 Furthermore, the enhancement of pancreatic FI induced by a high-fat diet can promote PDAC development via the elevation of adipokine/cytokine expression. 2 A combination of BOP treatment and a high-fat diet increased the amount of adipocytes infiltrating PDAC tissues compared to BOP treatment only. 2 When the PDACs were classified according to the degree of FI, the number of PDAC with FI within PDAC and its surrounding tissue was increased by a high-fat diet, but the number of PDACs without FI was unchanged. 
| Animal models of T2DM and hypertriglyceridemia
Initially, we hypothesized that hyperlipidemia and obesity might contribute to the susceptibility of hamsters to pancreatic cancer development, and we then attempted to develop PDAC in mice and rats with hyperlipidemia/T2DM. In our preliminary study, Apc Min mice were treated with BOP, but did not develop PDAC (data not shown).
OLETF rats also did not develop scattered FI in the pancreas and failed to develop PDAC after treatment with BOP. 39 These data indicated that T2DM with hypertriglyceridemia and/or hyperinsulinemia is not sufficient to increase susceptibility to pancreatic carcinogenesis. The pancreas of mice and rats seems to be resistant to lipotoxicity and chemical damage compared to that of hamsters, so we realized the importance of scattered intralobular FI in the pancreas for pancreatic carcinogenesis.
We then examined whether the mouse pancreas with intralobular FI was sensitive to BOP-induced pancreatic ductal proliferation. A single high dose of BOP treatment increased pancreatic ductal cell proliferation in KK-A y mice, but not in ICR, C57BL/6J and C57BL/6J-A y mice (Figure 2A) . 58 In addition, cell proliferation in common bile ducts was enhanced by BOP treatment in KK-A y and C57BL/6J-A y mice ( Figure 2B ). 58 These data suggest that scattered FI in the pancreas may be an important factor for carcinogenesis. However, our There is another species difference related to pancreatic carcinogenesis in glucocorticoid hormone production. Glucocorticoids are stress hormones that play anti-inflammatory, but immune-suppressive, roles. 60 There are species differences in the substrate affinity for 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which catalyzes the intracellular activation of glucocorticoids. 61 Corticosterone is the major glucocorticoid in mice and rats, whereas cortisol is the major glucocorticoid in humans. Hamsters secrete both cortisol and corticosterone, and chronic stress increases cortisol. 62 Immune suppression caused by cortisol may also be involved in the pancreatic cancer susceptibility of hamsters. Female Syrian golden hamsters were subcutaneously injected with N-nitrosobis(2-oxopropyl)amine (BOP) (at a dose of 10 mg/kg body weight, 4 times a week) or vehicle (saline) at 6 wk of age and were fed a high-fat diet or standard diet from 1 wk after the last injection for 6 or 17 wk. 
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The adipocyte-infiltrated areas in the pancreas are significantly greater in the cases than in the controls (median 25.8% vs 15.0%, P < .001). 18 In these cases, The proportion of subjects with an area of FI <10%, 10%-20%, and ≥20% in the pancreas were almost the same in controls, but more than 60% of cases had an area of FI ≥20% in the pancreas (Figure 4 ). 
| Pancreatic intraepithelial neoplasia (PanIN)
Recently, Rebours et al. 64 
| Dissemination and poor prognosis
Mathur et al. 65 conducted a case-control analysis in node-positive/ negative patients who had resected PDAC. The mean number of adipocytes in the pancreas of cases was significantly high (P < .02), and the fibrosis score was significantly low (P < .02) compared with those of controls. The mean survival was reduced in cases (18.9 months vs 30.8 months; P < .04). 65 Cases had increased visceral fat, but not subcutaneous fat, compared to controls, and the mean survival in cases with a perineal fat pad ≥10 mm was poorer than that of controls with a perineal fat pad <10 mm (7 months vs 16 months; P < .01). 66 These observations suggest that pancreatic FI promotes the dissemination and lethality of PDAC.
F I G U R E 3 Associations of age (A,B), body mass index (BMI) (C,D) and HbA1c (E,F) levels with pancreatic fatty infiltration (FI) areas in pancreatic cancer cases (n = 102) and controls (n = 85). The data were obtained from our previous study. 18 Scatter plots of FI of the pancreas against age for cases (A) and controls (B), BMI for cases (C) and controls (D), and HbA1c for cases (E) and controls (F). r, Spearman's rank correlation coefficient
| PUTATIVE MECHANISMS TH AT EXPLAIN THE MODULATION OF PANCREATIC CARCINOGENESIS THROUGH FATTY PANCREAS
| Secretion of adipokines and growth factors
Adipocytes secrete pro-inflammatory adipokines/cytokines, such as leptin and monocyte chemotactic protein-1 (MCP-1). 67 Leptin has been reported to increase cancer cell proliferation via the up-regulation of Notch signaling, 68 and MCP-1 induces inflammation via macrophage recruitment. 67 Adipocytes also secrete insulin-like growth factor (IGF-1), which regulates the differentiation and growth of tissues, 69 and angiotensin II, which regulates lipogenesis. 70 Leptin and angiotensin II increase the angiogenesis and lymphatic metastasis of PDAC by producing vascular endothelial growth factor (VEGF). 71, 72 A high-fat diet increased the expression of these genes in the pancreas of BOP-treated hamsters. 2 These proliferation and inflammatory factors derived from infiltrated adipocytes may be involved in tumor promotion. In addition, it has been reported that the C-X-C motif ligand 5 (CXCL5) secreted by adipose tissue-derived mesenchymal stem cells has neurotrophic effects 73 and is involved in inflammation and insulin resistance in adipose tissue. 67 Overexpression of CXCL5 induced angiogenesis and was associated with poor survival in PDAC patients. 74 
| Others
Meyer et al. 75 reported that a co-culture of murine 3T3L1 adipocytes with PanIN/PDAC cells derived from PKCY mice, which had pancreas-specific mutant K-ras expression and p53 deletion, pro- shown to be associated with severe FI. 77 A neurotrophic microenvironment created by FI may be involved in pancreatic cancer promotion. In obesity, cortisol secretion is increased by 11β-HSD1 in adipocytes 78 and may increase tumor development and metastasis through its immuno-suppressive actions. 
